The effect of etrasimod on faecal calprotectin and high-sensitivity C-reactive protein: Results from the ELEVATE UC clinical programme

被引：0

作者：

Jairath, V. ^{[1
,2
]}

Rubin, D. T. ^{[3
]}

Verstockt, B. ^{[4
,5
]}

Cekin, A. H. ^{[6
]}

Abreu, M. T. ^{[7
]}

Lees, C. W. ^{[8
,9
]}

Fellmann, M. ^{[10
]}

Woolcott, J. C. ^{[11
]}

Crosby, C. ^{[12
]}

Wu, J. ^{[13
]}

Bhattacharjee, A. ^{[14
]}

Herman, D. ^{[12
]}

Gu, G. ^{[12
]}

Siegmund, B. ^{[15
,16
,17
,18
]}

机构：

[1] Western Univ, Dept Med, London, ON, Canada

[2] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada

[3] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Sect Gastroenterol Hepatol & Nutr, Chicago, IL USA

[4] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium

[5] Katholieke Univ Leuven, Translat Res GI Disorders, Dept Chron Dis & Metab, Leuven, Belgium

[6] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Gastroenterol, Antalya, Turkiye

[7] Univ Miami, Miller Sch Med, Dept Med, Crohns & Colitis Ctr,Div Gastroenterol, Miami, FL 33136 USA

[8] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland

[9] NHS Lothian, Western Gen Hosp, Edinburgh IBD Unit, Edinburgh, Midlothian, Scotland

[10] Pfizer AG, Zurich, Switzerland

[11] Pfizer Inc, Collegeville, PA USA

[12] Pfizer Inc, La Jolla, CA USA

[13] Pfizer Inc, Cambridge, MA USA

[14] Pfizer Healthcare India Pvt Ltd, Chennai, Tamil Nadu, India

[15] Charite Univ Med Berlin, Med Klin Gastroenterol Infektiol Rheumatol, Berlin, Germany

[16] Free Univ Berlin, Berlin, Germany

[17] Humboldt Univ, Berlin, Germany

[18] Campus Benjamin Franklin, Berlin, Germany

来源：

JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P788

引用

页码：I1458 / I1460

页数：3

共 50 条

[31] High-Sensitivity C-Reactive Protein and Statin Initiation
Trpkovic, Andreja
Stanimirovic, Julijana
Rizzo, Manfredi
Resanovic, Ivana
Soskic, Sanja
Jevremovic, Danimir
Isenovic, Esma R.
ANGIOLOGY, 2015, 66 (06) : 503 - 507
[32] Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme
Regueiro, Miguel
Siegmund, Britta
Yarur, Andres J.
Steinwurz, Flavio
Gecse, Krisztina B.
Goetsch, Martina
Bhattacharjee, Abhishek
Wu, Joseph
Green, Jesse
McDonnell, Aoibhinn
Crosby, Catherine
Lazin, Krisztina
Branquinho, Diogo
Modesto, Irene
Abreu, Maria T.
JOURNAL OF CROHNS & COLITIS, 2024, 18 (10): : 1596 - 1605
[33] High-sensitivity C-reactive protein and atherosclerosis: From theory to therapy
Yu, H
Rifai, N
CLINICAL BIOCHEMISTRY, 2000, 33 (08) : 601 - 610
[34] The Clinical Utility of Standard and High-Sensitivity C-Reactive Protein: A Narrative Review
Fatima Zahra Rahali
Nidae Mimouni
Abderrahman Boukhira
Saliha Chellak
SN Comprehensive Clinical Medicine, 6 (1)
[35] The Role and Clinical Significance of High-Sensitivity C-Reactive Protein in Cardiovascular Disease
Seo, Hong Seog
KOREAN CIRCULATION JOURNAL, 2012, 42 (03) : 151 - 153
[36] Limited clinical utility of high-sensitivity plasma C-reactive protein assays
Elfatih, A
Chatha, K
Anderson, NR
Gama, R
ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 536 - 537
[37] Limited clinical utility of high-sensitivity plasma C-reactive protein assays
Campbell, B
Badrick, T
Flatman, R
Kanowski, D
ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 : 85 - 88
[38] The Application of High-Sensitivity C-Reactive Protein in Clinical Practice A 2015 Update
Knight, Michelle L.
US PHARMACIST, 2015, 40 (02) : 50 - 53
[39] Point - High-sensitivity C-reactive protein and cardiac C-reactive protein assays: Is there a need to differentiate?
Rifai, Nader
Ballantyne, Christie M.
Cushman, Mary
Levy, Daniel
Myers, Gary L.
CLINICAL CHEMISTRY, 2006, 52 (07) : 1254 - 1256
[40] High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study
Horn, Carla Schulze
Ilg, Ruediger
Sander, Kerstin
Bickel, Horst
Briesenick, Claus
Hemmer, Bernhard
Poppert, Holger
Sander, Dirk
JOURNAL OF NEUROLOGY, 2009, 256 (05) : 783 - 791

← 1 2 3 4 5 →